Article

[Prevention and treatment of osteoporosis during treatment of non-metastatic prostate cancer].

Kardiologisk-endokrinologisk Afdeling H, Hillerød Hospital, Dyrehavevej 29, 3400 Hillerød, Denmark.
Ugeskrift for laeger 11/2011; 173(48):3093-6.
Source: PubMed

ABSTRACT The prevention of cancer treatment-induced bone loss in patients with prostate cancer due to gonadotropin-releasing hormone (GnRH)-agonist, GnRH-antagonist and orchidectomi therapy has a high priority. We present an algorithm for the prevention and treatment of osteoporosis during treatment of non-metastatic prostate cancer.

0 Bookmarks
 · 
132 Views